Brought to you by 
Aldeyra Therapeutics nets $11.2mm in IPO
03 Jun 2014
Executive Summary
Aldeyra Therapeutics Inc., working on drug candidates that trap and help dispose of free aldehydes, netted $11.2mm in its initial public offering of 1.5mm shares at $8. When the company initially filed in January, it was known as Aldexa Therapeutics, but changed its name to Aldeyra in March, the same time it proposed selling 2mm shares between $10-12 each, then a few days later upped the number of shares to 2.3mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com